Should You Buy, Sell or Hold MSTR Stock Before Q3 Earnings?
Should You Buy, Sell or Hold MSTR Stock Before Q3 Earnings? Zacks Investment Research
Covered in this story
Analyst targets on MicroStrategy
- Barclays: $137 → $175 by Oct 2027 · Overweight via CryptoRank
- Cantor Fitzgerald: $137 → $208 by Oct 2027 · Overweight via Investing.com
- Canaccord Genuity: $127 → $175 by Aug 2027 · Buy via Yahoo Finance
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $MSTR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on MicroStrategy →Dalsna Finance is currently tracking 43 stories mentioning MicroStrategy, the earliest published 30 Apr 2026.
Summary aggregated from Zacks Investment Research's public RSS feed. The full reporting belongs to Zacks Investment Research — please read it on their site.